Strongbridge Biopharma plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAXTON CORP | 11/15/2021 | 8.02 M | $16.37 M | -0.73% | 11.86% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/12/2021 | 4.49 M | $9.16 M | 35.82% | 6.64% |
| NEA MANAGEMENT COMPANY, LLC | 11/12/2021 | 4.14 M | $8.45 M | 0.00% | 6.12% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/12/2021 | 3.07 M | $6.27 M | 13.98% | 4.54% |
| VANGUARD GROUP INC | 11/12/2021 | 2.20 M | $4.49 M | 0.00% | 3.25% |
| MAN GROUP PLC | 11/15/2021 | 1.97 M | $4.01 M | 100.00% | 2.91% |
| MORGAN STANLEY | 11/15/2021 | 1.77 M | $3.62 M | -9.35% | 2.62% |
| TUDOR INVESTMENT CORP ET AL | 11/17/2021 | 1.53 M | $3.12 M | 0.00% | 2.26% |
| RENAISSANCE TECHNOLOGIES LLC | 11/12/2021 | 1.37 M | $2.80 M | -3.96% | 2.03% |
| ORBIMED ADVISORS LLC | 11/15/2021 | 794,675 | $1.62 M | -54.45% | 1.17% |
| MILLENNIUM MANAGEMENT LLC | 11/15/2021 | 583,163 | $1.19 M | -8.60% | 0.86% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2021 | 576,979 | $1.18 M | 4.23% | 0.85% |
| WEISS ASSET MANAGEMENT LP | 11/12/2021 | 494,093 | $1.01 M | -9.69% | 0.73% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2021 | 466,863 | $952,000 | 0.00% | 0.69% |
| YAKIRA CAPITAL MANAGEMENT, INC. | 11/12/2021 | 341,303 | $696,000 | 0.00% | 0.50% |
| OMERS ADMINISTRATION CORP | 11/12/2021 | 210,401 | $429,000 | -12.08% | 0.31% |
| BLACKROCK INC. | 11/09/2021 | 201,840 | $412,000 | -7.57% | 0.30% |
| DIVERSIFIED TRUST CO | 01/13/2022 | 198,534 | $405,000 | 0.00% | 0.29% |
| GOLDMAN SACHS GROUP INC | 01/20/2022 | 196,365 | $400,000 | -51.19% | 0.29% |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | 11/17/2021 | 193,107 | $392,000 | 0.00% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/15/2021 | 155,457 | $317,000 | 310.30% | 0.23% |
| ERGOTELES LLC | 04/21/2022 | 153,518 | $313,000 | -85.99% | 0.23% |
| TWO SIGMA ADVISERS, LP | 11/15/2021 | 150,600 | $307,000 | -40.38% | 0.22% |
| STATE STREET CORP | 11/15/2021 | 137,728 | $281,000 | 6.25% | 0.20% |
| JANE STREET GROUP, LLC | 11/16/2021 | 121,202 | $247,000 | 46.25% | 0.18% |
| HRT FINANCIAL LP | 11/15/2021 | 96,533 | $196,000 | -22.22% | 0.14% |
| PRINCIPAL FINANCIAL GROUP INC | 11/09/2021 | 93,064 | $190,000 | -0.74% | 0.14% |
| NORTHERN TRUST CORP | 11/15/2021 | 87,885 | $179,000 | -3.15% | 0.13% |
| CSS LLC/IL | 11/15/2021 | 82,368 | $168,000 | 5.10% | 0.12% |
| CAPTION MANAGEMENT, LLC | 11/12/2021 | 52,634 | $107,000 | -13.29% | 0.08% |
| BANK OF NEW YORK MELLON CORP | 11/18/2021 | 51,948 | $106,000 | 0.00% | 0.08% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 11/15/2021 | 44,032 | $90,000 | -22.18% | 0.07% |
| IEQ CAPITAL, LLC | 11/09/2021 | 41,756 | $85,000 | 0.00% | 0.06% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/15/2021 | 36,100 | $74,000 | 0.00% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/15/2021 | 23,400 | $48,000 | -26.18% | 0.03% |
| VEERY CAPITAL, LLC | 10/13/2021 | 16,000 | $33,000 | 0.00% | 0.02% |
| WELLS FARGO & COMPANY/MN | 11/15/2021 | 13,203 | $27,000 | -0.11% | 0.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/15/2021 | 11,200 | $23,000 | -29.56% | 0.02% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/15/2021 | 11,053 | $23,000 | 100.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/15/2021 | 10,611 | $22,000 | -78.31% | 0.02% |
| TSFG, LLC | 10/12/2021 | 7,000 | $14,000 | 0.00% | 0.01% |
| BARCLAYS PLC | 11/09/2021 | 6,969 | $14,000 | -86.02% | 0.01% |
| UBS GROUP AG | 11/15/2021 | 5,188 | $11,000 | -80.38% | 0.01% |
| FIRST QUADRANT LLC/CA | 10/26/2021 | 3,100 | $6,000 | -62.20% | 0.00% |
| JPMORGAN CHASE & CO | 11/12/2021 | 3,000 | $6,000 | -51.27% | 0.00% |
| ROYAL BANK OF CANADA | 11/15/2021 | 2,937 | $6,000 | -72.18% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/16/2021 | 1,962 | $4,002 | -21.86% | 0.00% |
| PENSERRA CAPITAL MANAGEMENT LLC | 11/15/2021 | 1,520 | $3,000 | 100.00% | 0.00% |
| FMR LLC | 02/14/2022 | 650 | $1,000 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/05/2021 | 10 | $0 | 100.00% | 0.00% |
Strongbridge Biopharma plcinstitutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of Strongbridge Biopharma plc. The most heavily invested institutionals were:
Alambic Investment Management, L.P.: 54,164
Broadfin Capital, LLC: 0
Delpha Capital Management, LLC: 0
BLACKROCK ADVISORS LLC: 30,582
BlackRock Fund Advisors: 26,448
BlackRock Investment Management, LLC: 1,959
50.57% of Strongbridge Biopharma plc stock is owned by institutional investors.
Institutional investors have bought a total of 114,757 shares in the last 24 months. This purchase volume represents approximately $229,514 in transactions.